Ethnicity

Black women with lower Oncotype DX Recurrence Scores had worse survival than women of other races with similar scores.

Research analyzing breast cancer death rates suggests Black women should start screening earlier than women of other races and ethnicities.

A tumor’s genetics — which varies by race — affects how a breast cancer responds to neoadjuvant chemotherapy and may contribute to differences in outcomes between Black and white women.

Black women at high risk of developing breast cancer face a number of barriers to risk-reducing care.

Breast cancer characteristics and environment equally contribute to worse breast cancer survival rates among Black women.

Black people diagnosed with breast or prostate cancer were less likely to receive radiation on a shorter, or hypofractionated, schedule.

Black women who smoked when they were diagnosed with breast cancer were more likely to die from any cause.

Participation by American Indian or Alaska Native, Asian or Pacific Islander, Black, and Hispanic or Latin American people in phase I clinical trials for metastatic cancer drugs declined from 2000 to 2018.

Among people with Medicare, Black women had less access to newer mammogram technology than white women.

Stage I and stage II hormone receptor-positive breast cancer was more likely to shrink after hormonal therapy before surgery in Black women than in white women. But Black women had worse outcomes than white women if the breast cancer was a higher stage.

When more Black women diagnosed with early-stage, triple-negative breast cancer joined a study on Imfinzi, the results showed the immunotherapy was as effective in Black women as it was in women of other races and ethnicities.

Women from various racial and ethnic backgrounds, particularly Black women, had a higher risk of biopsy delays after an abnormal mammogram than white women.

Among women who had breast cancer surgery and axillary lymph node dissection, Black and Hispanic women were more likely to develop lymphedema than white women, as were women who received chemotherapy before surgery, rather than after surgery.

Many Black people diagnosed with metastatic breast cancer never find out about clinical trials from their doctors even though most of them are open to participating in one.

Black and Hispanic women who had low levels of vitamin D in their blood were more likely to develop breast cancer than women with sufficient levels.

Among Black people and white people diagnosed with cancer and COVID-19, Black people had worse COVID outcomes than white people.

Breast cells in Black women express DNA repair genes differently from breast cells in white women and may be part of the reason why Black women are 41% more likely to die from breast cancer than white women.

A study suggests Black women are about 3.5 times more likely to develop lymphedema than white women.

Black, Hispanic, American Indian, and Alaskan Native people are vastly underrepresented in research studies on breast, prostate, lung, and colorectal cancer.

Identifying and offering solutions for obstacles that kept people from completing radiation therapy for early-stage breast and lung cancer improved outcomes and seemed to eliminate the difference in survival rates between Black and white people.

Black women are 2.7 times more likely to be diagnosed with triple-negative breast cancer than white women, according to a study of risk factors in more than 198,000 women.

Breast cancer death rates decreased among all racial and ethnic groups from 1990 to 2015 in Florida, but Black women were still twice as likely to die from breast cancer as white women.

Black women diagnosed with breast cancer who also have central obesity — excess body fat in the abdominal area — were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity.

Black women and white women diagnosed with breast cancer have about the same rates of genetic mutations linked to a higher risk of breast cancer.